M. Brandt

Comparative Erythropoietin Receptor Binding Kinetics of C.E.R.A. and Epoetin-β Determined by Surface Plasmon Resonance and Competition Binding Assay

M. Jarsch, M. Brandt, M. Lanzendörfer, 2007, Pharmacology.

A Linear Epitope in the N-Terminal Domain of CCR5 and Its Interaction with Antibody

B. Chain, N. Chayen, E. Saridakis, 2015, PloS one.

Target-mediated drug disposition and prolonged liver accumulation of a novel humanized anti-CD81 monoclonal antibody in cynomolgus monkeys

Rosario Garrido, V. Vexler, K. Klumpp, 2013, mAbs.

Epitope Switching as a Novel Escape Mechanism of HIV to CCR5 Monoclonal Antibodies

S. Sankuratri, A. Lochner, N. Cammack, 2010, Antimicrobial Agents and Chemotherapy.

Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen.

W. Scherbaum, C. Thivolet, J. Endl, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Prevention of hepatitis C virus infection and spread in human liver chimeric mice by an anti‐CD81 monoclonal antibody

W. Rubas, K. Klumpp, M. Brandt, 2015, Hepatology.

Novel CCR5 monoclonal antibodies with potent and broad-spectrum anti-HIV activities.

Jun Zhang, M. Dioszegi, S. Sankuratri, 2007, Antiviral research.

CCR5 Small-Molecule Antagonists and Monoclonal Antibodies Exert Potent Synergistic Antiviral Effects by Cobinding to the Receptor

Jun Zhang, M. Dioszegi, S. Sankuratri, 2007, Molecular Pharmacology.

The Second Extracellular Loop of CCR5 Contains the Dominant Epitopes for Highly Potent Anti-Human Immunodeficiency Virus Monoclonal Antibodies

Jun Zhang, M. Dioszegi, S. Sankuratri, 2007, Antimicrobial Agents and Chemotherapy.

Development of Tetravalent, Bispecific CCR5 Antibodies with Antiviral Activity against CCR5 Monoclonal Antibody-Resistant HIV-1 Strains

U. Brinkmann, Jun Zhang, J. Nezu, 2011, Antimicrobial Agents and Chemotherapy.